ValuEngine lowered shares of Phibro Animal Health Corporation (NASDAQ:PAHC) from a buy rating to a hold rating in a research note published on Thursday morning.

Several other equities analysts have also weighed in on PAHC. Zacks Investment Research lowered shares of Phibro Animal Health Corporation from a hold rating to a sell rating in a research report on Wednesday. Piper Jaffray Companies set a $42.00 price objective on shares of Phibro Animal Health Corporation and gave the company a buy rating in a research report on Friday, August 25th. BidaskClub lowered shares of Phibro Animal Health Corporation from a strong-buy rating to a buy rating in a research report on Wednesday, August 23rd. Bank of America Corporation reaffirmed an underperform rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Finally, Credit Suisse Group raised their price objective on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an outperform rating in a research report on Thursday, August 31st. Two research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of Hold and an average target price of $38.25.

Shares of Phibro Animal Health Corporation (PAHC) traded up $0.45 on Thursday, reaching $34.60. 74,500 shares of the company traded hands, compared to its average volume of 78,865. The company has a market capitalization of $1,380.09, a price-to-earnings ratio of 22.61, a PEG ratio of 4.06 and a beta of 1.35. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.75 and a current ratio of 3.26. Phibro Animal Health Corporation has a 52-week low of $26.10 and a 52-week high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. The firm had revenue of $193.40 million for the quarter, compared to analyst estimates of $189.89 million. Phibro Animal Health Corporation had a net margin of 8.87% and a return on equity of 42.75%. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.36 earnings per share. research analysts expect that Phibro Animal Health Corporation will post 1.57 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “ValuEngine Lowers Phibro Animal Health Corporation (PAHC) to Hold” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.watchlistnews.com/valuengine-lowers-phibro-animal-health-corporation-pahc-to-hold/1698795.html.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is Tuesday, December 5th. Phibro Animal Health Corporation’s dividend payout ratio is 23.53%.

In other news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $35.70, for a total value of $357,000.00. Following the transaction, the insider now owns 10,000 shares of the company’s stock, valued at $357,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Larry Lee Miller sold 15,891 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $36.46, for a total transaction of $579,385.86. Following the completion of the transaction, the chief operating officer now directly owns 15,891 shares in the company, valued at approximately $579,385.86. The disclosure for this sale can be found here. In the last three months, insiders sold 292,448 shares of company stock worth $10,624,994. Insiders own 51.88% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. grew its stake in shares of Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock worth $650,000 after acquiring an additional 46 shares during the last quarter. Louisiana State Employees Retirement System grew its stake in shares of Phibro Animal Health Corporation by 1.3% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $282,000 after acquiring an additional 100 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock worth $363,000 after acquiring an additional 100 shares during the last quarter. Nationwide Fund Advisors grew its stake in shares of Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock worth $403,000 after acquiring an additional 110 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan grew its stake in shares of Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after acquiring an additional 150 shares during the last quarter. Institutional investors and hedge funds own 49.87% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.